The purpose of this study is to improve the sense of hope and build resilience through creating one’s Tree of Hope. This study is being done because we see that today’s environment is quite stressful and this can lead to people feeling less hopeful in their present and the future.
- At least 18 years old
- Able to read and understand English
- Healthy people and patients will be eligible for this research study
- Participants will be eligible even if they are not seen at OSU for their care.
- We will not abstract any data from electronic health records. Patients will complete a survey that asks them questions about their health conditions
- Any physical or mental condition that the principal investigator considers as impacting the ability of the patient to participate in the research study. Examples include visual or hearing impairment, arthritis, weakness or other medical problem that impairs their ability to write.
The purpose of this study is to test whether changes in the way in which we react and respond to emotional or stressful information represent a risk factor for depression in kids of mothers with and without depression. Findings from the study have the potential to decrease the high rates of depression observed in children of depressed mothers.
You may be eligible for this study if:
- You are 18-65 years old and female.
- You have a biological child who is between 9 and 14 years of age.
The purpose of this study is to examine whether fear of uncertainty plays a role in home safety practices among firearm owners who are currently or have recently served in the U.S. military.
- Currently serving in any Branch or Component of the U.S. military, or were discharged from the U.S. military within the past 90 days
- 18 years or older
- Own at least one firearm located in your home or vehicle
- Are able to speak and understand the English language
- Have an Apple or Android smartphone
This study aims to explore how East Asian American caregivers of persons with dementia seek help and use services for their own mental health from their surroundings in order to reduce stress, anxiety, sadness, and any other negative thoughts and feelings.
We will include individuals who are:
1) primary, informal, and unpaid caregivers of persons living with dementia,
2) 18 years or older,
3) self-identifying as East Asian Americans (e.g., Chinese, Korean, Japanese, Mongolian, Tibetan, and Taiwanese),
4) immigrants (i.e., first-generation) or children of the first-generation East Asian Americans (i.e., second-generation),
5) fluent in English, and
6) willing to participate.
The purpose of this study is to examine health outcomes in former Ohio State University athletes who played a varsity sport during their time at OSU. The objective is to determine whether athletes who sustained a concussion have different health outcomes than those who did not sustain a concussion. Any former OSU varsity athlete can participate in a 20-minute online survey.
- Anyone who has played a varsity sport as an undergraduate student at OSU, and they have now graduated (i.e., OSU athlete alumni). There are no other restrictions in terms of age, sex/gender, type of sport, etc.
The purpose of this study is to determine the feasibility of a group delivered intervention for stress and blood pressure in African American women caregivers.
- Diagnosis of HTN treated with an antihypertensive medication or risk of HTN that includes obesity and high cholesterol
- Age 40 and older
- A caregiver rating of the PLWD of 2 or greater on the Alzheimer’s Dementia-8 scale
- Caregiver provides unpaid care to a PLWD at least 10 hours per week or assists with at least one instrumental activity of daily living
- Self-identifies as Black/African American
- English speaking
- Access to a telecommunications device such as the internet via desktop, laptop/tablet, smartphone, or telephone
The purpose of this study is to see if BELSOMRA, an FDA approved medication that is prescribed to treat insomnia, changes the body’s response to stress. Participation in the study includes 3 or 5 in-person lab visits (depending on randomization), which include EEG and MRI. Nearly all visits are 1.5 hours long, with the exception of one that is 4-5 hours in duration. Visits are flexible and scheduled at your convenience. Participants take the medication (or placebo) for 4 weeks, during which participation is only composed of virtual surveys via a smartphone app.
The total length of participation in the study is 1.5-2 months depending on scheduling/availability.
- 18-65 years old
- Generally medically and physically healthy
- Regular alcohol use
- Diagnosis of bipolar disorder, schizophrenia, mania, or psychosis
- Currently pregnant or trying to become pregnant (female)
- Presence of ferrous-containing metal in the body
- Inability to tolerate enclosed spaces
Exclusion Criteria varies, please contact Study Coordinator for more information.
The purpose of this study is to investigate the early development of attention, learning, and memory during childhood. Participation in this study includes 4, 90-minute-long visits to the lab per year. During these visits, your child will play 2-3 fun, computerized games. These games are designed to assess various aspects of their cognitive ability.
The duration of the study will last 4 years.
- African-American/Black children who are 4 years old
The purpose of the study is to determine if the investigational study drug will rapidly reduce depression associated with thoughts of harming oneself when given in addition to standard antidepressant medication.
Your participation in this study will last for a minimum of 14 weeks and maximum of 58 weeks.
• Aged 18-65 years old
• Diagnosed with major depressive disorder (MDD) with a current major depressive episode
• Having current suicidal ideation with intent
• Already in the hospital or agree to be hospitalized voluntarily for the required period of time
This study is being done to see if the study drug, called BI 1358894, compared to a drug called quetiapine, may help people with Major Depressive Disorder (MDD) who do not progress when taking an antidepressant medication alone. This study will help to gain information for providing better or new possible treatments for people in the future.
This study will take place over a period of 13 weeks and have about 8 visits to the study center and 2 that will be done by phone.
• Aged 18-65 years old
• Diagnosed with Major Depressive Disorder (MDD)
• Currently depressed
• Taking an antidepressant